15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 14 firms covering RXO Inc, 4 rate it Buy or better, 8 sit at Hold, and 2 rate it Sell or worse, a hold consensus. Targets span $20.00 to $35.00, a moderate spread. The average target of $26.30 sits 16% above the current $22.65. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.04 next quarter toward $0.53 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS14 ratings
Hold
Strong Buy00%
Buy429%
Hold857%
Sell214%
Strong Sell00%
Based on 14 analysts giving stock ratings to RXO Inc.
As of Jul, 4 of 14 firms rate RXO a Buy (8 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
RXO EPS & revenue forecast
EPS · NEXT QUARTER
$0.04
Range $0.00 – $0.07 · 18 analysts · +270% YoY
Next period, 18 analysts expect RXO Inc. to earn $0.04 a share (range $0.00 – $0.07), versus $0.01 a year earlier. Full-year consensus is $0.07, growing to $0.53 the year after.
REVENUE · NEXT QUARTER
$1.6B
Range $1.5B – $1.8B · 18 analysts · +15% YoY
Revenue is expected to reach $1.6B (range $1.5B – $1.8B), +14.9% year-over-year. Full-year consensus is $6.3B, rising to $6.9B next year.
Top analysts covering RXO Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on RXO.
#1
Brandon Oglenski
Barclays · Rank #55
Buy
$28.00+23.6% to target
Overall win rate
45%
+ Follow
#2
Ken Hoexter
B of A Securities · Rank #199
Hold
$29.00+28.0% to target
Overall win rate
44%
+ Follow
#3
JB
J. Bruce Chan
Stifel
Buy
$30.00+32.5% to target
Coverage
—
+ Follow
#4
Ariel Rosa
Citigroup
Hold
$30.00+32.5% to target
Coverage
—
+ Follow
#5
Thomas Wadewitz
UBS
Hold
$26.00+14.8% to target
Coverage
—
+ Follow
RXO stock forecast FAQ
What is RXO's average 12-month price target?+
The 10 analysts with a live target average $26.30 for RXO Inc. over the next 12 months, ranging from a $35.00 high to a $20.00 low.
Is RXO stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 14 analyst ratings, 4 are Buy or Strong Buy, 8 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for RXO?+
The Street-high target is $35.00 (BMO Capital), and the Street-low is $20.00 (Goldman Sachs). The average of all 10 active targets is $26.30.
How many Wall Street analysts cover RXO?+
14 analysts have an active rating on RXO Inc., and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering RXO?+
Among analysts who currently cover RXO, Brandon Oglenski of Barclays has the strongest overall Quantellect track record (Rank #55). Their current call is Buy with a $28.00 target.
What is RXO Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.04 per share (range $0.00 – $0.07) across 18 analysts. Full-year EPS is projected at $0.07, rising to $0.53 the following year.
How much revenue is RXO Inc. expected to report next quarter?+
Consensus revenue is $1.6B (range $1.5B – $1.8B). Full-year revenue is projected at $6.3B, growing to $6.9B next year.
Have analysts been upgrading or downgrading RXO lately?+
As of Jul, 4 of 14 firms rate RXO a Buy (8 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their RXO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
